EP Patent

EP2363111A1 — Stable pharmaceutical composition comprising bisphosphonate

Assigned to Combino Pharm SL · Expires 2011-09-07 · 15y expired

What this patent protects

It comprises a stable liquid pharmaceutical product in a glass container, said pharmaceutical product comprising bisphosphonate, obtainable by a process comprising: (i) mixing the bisphosphonate with at least one pharmaceutically acceptable excipient in an appropriate solvent to …

USPTO Abstract

It comprises a stable liquid pharmaceutical product in a glass container, said pharmaceutical product comprising bisphosphonate, obtainable by a process comprising: (i) mixing the bisphosphonate with at least one pharmaceutically acceptable excipient in an appropriate solvent to obtain a mixture, (ii) filling the mixture into the glass container, (iii) terminally heat sterilizing the filled glass container, and (iv) cooling the sterilized filled glass container within maximum 5 hours to at least room temperature.

Drugs covered by this patent

Patent Metadata

Patent number
EP2363111A1
Jurisdiction
EP
Classification
—
Expires
2011-09-07
Drug substance claim
No
Drug product claim
No
Assignee
Combino Pharm SL
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.